Log In
Don't have an account yet?
Sign Up
Forgotten Password
Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to Lite
Lankro Way,
Manchester,
M30 0LX
Includes Risk Score, Credit Limit, CCJs, Mortgages & Charges, Director & Secretary Timeline, Shareholders, Ownership & Group Stucture. Plus UNLIMITED updates and FREE documents!
F2G LTD
Private limited with Share Capital
Active - Accounts Filed
10 June 1998
72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology
Available to 24 Sep 2024. Next accounts due by 30 Sep 2025
For a full in-depth analysis on each of these directors, click any of the links below
Name | Role | Date Of Birth | Appointed |
---|---|---|---|
Mr Henry Bradford Skinner | Director | ||
Mr Tobias George Sykes | Director | ||
Dr Nanna Liebach Luneborg | Director | ||
Dr Joseph Anderson | Director | ||
Dr Sylvie Louise Gregoire | Director | ||
Ms Camilla Soenderby | Director | ||
Mr Francesco Maria Lavino | Director | ||
Dr William Henry Lewarne West | Director | ||
Mr Naveed Siddiqi | Director | ||
Mr Timothy Anderson | Director | ||
Dr Patrick Volkert Jozef Johannes Vink | Director | ||
Mr Kaasim Mahmood | Director | ||
Dr Michael Birch | Company Secretary | ||
Ms Suzanne Lynne Powell | Company Secretary |
2
6
Type | Created | Registered | Persons Entitled | Status |
---|---|---|---|---|
European Investment Bank | OUTSTANDING | |||
Debenture | K/s Bi Biomedical Venture Annex Iii Merifin Capital N.v. K Nominees Limited And Astellas Ventur | SATISFIED | ||
Rent Deposit Deed | Akcros Chemicals Limited | OUTSTANDING | ||
Debenture | K/s Bi Biomedical Venture Annex Iii, Merifin Capital N.v, K Nominees Limited(The Lenders) | SATISFIED | ||
Rent Deposit Deed | Akcros Chemicals Limited | SATISFIED | ||
Debenture | P/s Bi Biomedicinsk Venture Iii, Merifin Capital N.v. And K Nominees | SATISFIED | ||
Debenture | P/s Bi Biomedicinsk Venture Iii, Merifin Capital N.v. And K Nominees Limited | SATISFIED | ||
Debenture | Hsbc Bank PLC | SATISFIED |
Sign Up Today to unlock this company's full accounts
Accounts | |||||
---|---|---|---|---|---|
Cash | £19,099,642.00 | £23,531,929.00 | £7,818,662.00 | £98,851,438.00 | £50,457,366.00 |
Net Worth | -£14,207,216.00 | -£18,787,882.00 | -£42,703,248.00 | £28,675,917.00 | -£13,207,922.00 |
Total Current Liabilities | £3,641,540.00 | £6,381,802.00 | £12,135,789.00 | £14,657,540.00 | £6,857,388.00 |
Total Current Assets | £20,754,666.00 | £27,951,609.00 | £13,785,208.00 | £102,240,402.00 | £59,328,038.00 |